CIGNA Corporation (CI)

Check out top investors' recommendation for CI
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
237.00
 ? 
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
100%/0%
 ? 
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Description:
Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. The company's Commercial segment offers insured and self-insured medical, dental, behavioral health, vision, and prescription drug benefit plans, health advocacy programs, and other products and services. Its Government segment offers Medicare Advantage plans to seniors in 13 states and the District of Columbia, Medicare Part D plans in all 50 states and the District of Columbia, and Medicaid plans. The company's Group Disability and Life segment provides group long-term and short-term disability insurance, group life insurance, and accident and specialty insurance. Its Global Supplemental Benefits segment offers supplemental health, life, and accident insurance products, as well as offers individual Medicare supplement plans that provide retirees with federally standardized Medigap-style plans. The company's Run-off Reinsurance segment manages its run-off reinsurance coverage for risks written by other insurance companies under life and annuity policies and accident policies under guaranteed minimum death benefits and minimum income benefits contracts. Its Other Operations segment provides corporate owned life insurance that are permanent insurance contracts sold to corporations to offer life coverage for certain employees, as well engages in run-off settlement annuity business. The company distributes its products and services through insurance brokers and insurance consultants or directly to employers, unions, and other groups, as well as through the Internet. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Sector:
Industry:
Analyst
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
Return
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
Michael Wiederhorn Oppenheimer & Co. Buy   Jun 12, '18     237.00  Jun 12, '19  N/A 
Ana Gupte Dowling & Partners Securities, LLC Buy   Mar 09, '18     225.00  Mar 09, '19  N/A 
Ralph Giacobbe Credit Suisse Buy   Mar 09, '18       Mar 09, '19  N/A 
Gary Taylor Citi Buy   Mar 09, '18       Mar 09, '19  N/A 
David Windley Jefferies & Co. Buy   Mar 08, '18     248.00  Mar 08, '19  N/A 
Michael Wiederhorn Oppenheimer & Co. Buy   Mar 08, '18       Mar 08, '19  N/A 
Ana Gupte Dowling & Partners Securities, LLC Buy   Feb 02, '18     250.00  Feb 02, '19  N/A 
Michael Wiederhorn Oppenheimer & Co. Buy   Feb 01, '18     220.00  Feb 01, '19  N/A 
Sarah James Wedbush Securities Inc. Buy   Feb 01, '18     226.00  Feb 01, '19  N/A 
Christine Arnold Cowen And Company Buy   Feb 01, '18     240.00  Feb 01, '19  N/A 
David Windley Jefferies & Co. Buy   Jan 12, '18     243.00  Jan 12, '19  N/A 
Michael Wiederhorn Oppenheimer & Co. Buy   Nov 02, '17       Nov 02, '18  N/A 
Sarah James Wedbush Securities Inc. Buy   Oct 31, '17     191.00  Oct 31, '18  N/A 
Christine Arnold Cowen And Company Buy   Oct 23, '17     185.00  Oct 23, '18  N/A 
Raj Denhoy Jefferies & Co. Buy   Oct 10, '17     201.00  Oct 10, '18  N/A 
David Windley Jefferies & Co. Buy   Sep 05, '17     201.00  Sep 05, '18  N/A 
Sarah James Wedbush Securities Inc. Buy   Aug 06, '17     191.00  Aug 06, '18  N/A 
Michael Wiederhorn Oppenheimer & Co. Buy   Aug 04, '17     190.00  Aug 04, '18  N/A 
David Windley Jefferies & Co. Buy   Aug 04, '17     201.00  Aug 04, '18  N/A 
Scott Fidel Deutsche Bank Securities Buy   Aug 04, '17     196.00  Aug 04, '18  N/A 
< previous1234